• No results found

Cover Page The handle

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The handle"

Copied!
6
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

The handle http://hdl.handle.net/1887/20399 holds various files of this Leiden University dissertation.

Author: Speetjens, Frank

Title: Anti-colorectal cancer immunity: control ‘the force’!

Date: 2013-01-10

(2)

Anti-colorectal cancer immunity:

Control ‘the force’!

Frank Speetjens

(3)

representative figures from chapters 2-7.

© F.M. Speetjens, 2013, Warmond, the Netherlands.

All rights reserved. No part of this thesis may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording or any information storage or retrieval system, without prior written permission of the copyright owner.

ISBN: 978-94-6169-337-2

Cover design, lay-out and print:

Optima Grafische Communicatie, Rotterdam, the Netherlands

(4)

Anti-colorectal cancer immunity:

Control ‘the force’!

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden,

op gezag van de Rector Magnificus prof. mr. P.F. van der Heijden, volgens besluit van het College voor Promoties

te verdedigen op donderdag 10 januari 2013 klokke 16.15 uur

door

Franciscus Maria Speetjens geboren te Den Haag

in 1976

(5)

Co-promotor Dr. P.J.K. Kuppen

Overige leden Prof. dr. J.B.A.G. Haanen Prof. dr. C.J.M. Melief Prof. dr. H. Morreau

Prof. dr. H.W. Nijman (Rijksuniversiteit Groningen)

The author of this thesis is a MD-medical research trainee funded by the Netherlands

Organisation for Health Research and Development (grant nr. 92003509).

(6)

ContentS

Chapter 1 General Introduction 7

Chapter 2 Clinical impact of HLA class I expression in rectal cancer 27 Chapter 3 Natural killer cells infiltrating colorectal cancer and MHC class I

expression

45

Chapter 4 Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients

57

Chapter 5 Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer

77

Chapter 6 Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer

97

Chapter 7 Addition of Interferon-alpha to the p53-SLP

®

vaccine results in increased production of Interferon-gamma in vaccinated colorectal cancer patients: a phase I/II clinical trial

119

Chapter 8 Summary and future perspectives 143

Chapter 9 Nederlandse samenvatting List of publications Curriculum Vitae Dankwoord

159

Referenties

GERELATEERDE DOCUMENTEN

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/13147.

CD8+ T cells (cytotoxic T lymphocytes, CTL) recognize MHC class I molecules bearing short peptides present on all nucleated cells and CD4+ T cells (T helper cells) interact via

Now that we have shown that p53-specific Th1 responses can be efficiently induced in p53+/+ C57BL/6 mice by immunization with synthetic peptides comprising the identified

A) Full-length coding sequences of frameshift-mutated genes that lack stop codons were fused in frame to a sequence encoding the H-2Kb-restricted CD8+ T-cell epitope

Supplemental material.. Negative selection prevents development of p53 reactive CD8+ T cells. Total lymphocytes from thymus and spleen of mice with indicated genetic backgrounds

Nevertheless, even in case of T-cell tolerance, passive cell therapy by adoptive T cell transfer in this last antigen scenario could also lead to a robust T-cell response since

Pas als T-cellen deze antigenen niet herkennen kunnen ze volledig differentiëren en een functionele T-cel receptor en CD8 of CD4 moleculen tot expressie brengen zodat ze de

Pieters aan het Instute for Risk Assessment Sciences (IRAS) van de Universiteit Utrecht, werd zij in 2000 voor een jaar gekozen tot student-bestuurslid van de faculteit